Product
DSP-0546LP
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
A Single Center, Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1 Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine "fH1/DSP-0546LP" After Intramuscular (IM) Administrations in Healthy AdultsStatus: Not yet recruiting, Estimated PCD: 2026-03-27